Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT04289220 · UNKNOWN
Trial details
- NCT number
- NCT04289220
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-15
- Primary completion
- 2023-03-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.